135,663 Shares in The Cooper Companies, Inc. $COO Purchased by Concentric Capital Strategies LP

Concentric Capital Strategies LP acquired a new position in The Cooper Companies, Inc. (NASDAQ:COO) in the 4th quarter, according to its most recent filing with the Securities and Exchange Commission. The firm acquired 135,663 shares of the medical device company’s stock, valued at approximately $11,119,000. Concentric Capital Strategies LP owned approximately 0.07% of Cooper Companies as of its most recent filing with the Securities and Exchange Commission.

Several other large investors also recently bought and sold shares of the business. New York Life Investment Management LLC increased its holdings in Cooper Companies by 0.6% in the 4th quarter. New York Life Investment Management LLC now owns 27,344 shares of the medical device company’s stock worth $2,241,000 after buying an additional 158 shares in the last quarter. Root Financial Partners LLC increased its holdings in Cooper Companies by 104.5% in the 4th quarter. Root Financial Partners LLC now owns 317 shares of the medical device company’s stock worth $26,000 after buying an additional 162 shares in the last quarter. Allworth Financial LP increased its holdings in Cooper Companies by 14.1% in the 4th quarter. Allworth Financial LP now owns 1,355 shares of the medical device company’s stock worth $111,000 after buying an additional 167 shares in the last quarter. Mesirow Financial Investment Management Inc. increased its holdings in Cooper Companies by 1.3% in the 3rd quarter. Mesirow Financial Investment Management Inc. now owns 14,017 shares of the medical device company’s stock worth $961,000 after buying an additional 175 shares in the last quarter. Finally, Blue Trust Inc. increased its holdings in Cooper Companies by 13.9% in the 4th quarter. Blue Trust Inc. now owns 1,515 shares of the medical device company’s stock worth $124,000 after buying an additional 185 shares in the last quarter. 24.39% of the stock is currently owned by institutional investors.

Cooper Companies Trading Down 3.4%

Shares of NASDAQ:COO opened at $65.05 on Thursday. The stock has a market capitalization of $12.69 billion, a price-to-earnings ratio of 55.13, a PEG ratio of 1.76 and a beta of 0.87. The company has a debt-to-equity ratio of 0.23, a quick ratio of 0.78 and a current ratio of 1.27. The stock’s 50-day simple moving average is $64.58 and its two-hundred day simple moving average is $74.10. The Cooper Companies, Inc. has a 52-week low of $58.89 and a 52-week high of $89.83.

Cooper Companies (NASDAQ:COO) last announced its earnings results on Thursday, June 4th. The medical device company reported $1.21 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.10 by $0.11. Cooper Companies had a return on equity of 10.88% and a net margin of 5.57%.The business had revenue of $1.08 billion for the quarter, compared to analysts’ expectations of $1.05 billion. During the same period last year, the firm posted $0.96 earnings per share. The business’s revenue for the quarter was up 7.9% on a year-over-year basis. Cooper Companies has set its FY 2026 guidance at 4.580-4.660 EPS. Analysts expect that The Cooper Companies, Inc. will post 4.63 EPS for the current year.

Wall Street Analysts Forecast Growth

Several research analysts have issued reports on COO shares. Needham & Company LLC dropped their target price on Cooper Companies from $101.00 to $86.00 and set a “buy” rating on the stock in a research report on Friday, June 5th. Wells Fargo & Company reissued a “sell” rating and issued a $66.00 target price (down from $82.00) on shares of Cooper Companies in a research report on Friday, June 5th. Wall Street Zen cut Cooper Companies from a “buy” rating to a “hold” rating in a research report on Saturday, June 13th. Rothschild & Co Redburn cut Cooper Companies from a “buy” rating to a “neutral” rating and set a $85.00 target price on the stock. in a research report on Wednesday, March 4th. Finally, The Goldman Sachs Group set a $61.00 target price on Cooper Companies in a research report on Wednesday, May 27th. One research analyst has rated the stock with a Strong Buy rating, seven have issued a Buy rating, five have issued a Hold rating and three have assigned a Sell rating to the company. Based on data from MarketBeat, Cooper Companies presently has an average rating of “Hold” and a consensus price target of $81.31.

Cooper Companies Company Profile

Cooper Companies, Inc (NASDAQ: COO) is a global medical device company headquartered in San Ramon, California. Founded in 1958, the company has grown through strategic acquisitions and organic development to become a major provider of vision care and women’s health products. Cooper Companies operates through two primary business segments—CooperVision and CooperSurgical—each serving specialized markets within the healthcare industry.

The CooperVision segment develops, manufactures and markets a broad range of soft contact lenses, as well as related accessories.